In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir: Prospective Multicenter Randomized Trial Versus Placebo.

Trial Profile

In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir: Prospective Multicenter Randomized Trial Versus Placebo.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2012

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Cytomegalovirus infections
  • Focus Therapeutic Use
  • Acronyms CYMEVAL
  • Most Recent Events

    • 01 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 23 Feb 2011 Planned end date changed from 1 Oct 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 05 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top